Human Research Protection Alternative Models Discussed By OHRP’s Koski
This article was originally published in The Gray Sheet
Executive SummaryA human subjects protection strategy in which a central review panel works with a set of local review boards to improve safety for research participants is among several alternative models worth exploring, HHS Office of Human Research Protections Director Greg Koski, MD/PhD, told an Institute of Medicine Clinical Research Roundtable workshop Nov. 5
You may also be interested in...
ConMed's CFO Todd Garner told delegates at the Jefferies Healthcare conference that the company's orthopedic franchise is focused on its pipeline and meeting customer's needs. See what the CFO said about it here.
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.